Discontinuation report CLINIMIX

Last updated on 2020-11-18 History
Report ID 118601
Drug Identification Number 02142279
Brand name CLINIMIX
Common or Proper name CLINIMIX
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) HISTIDINE L-THREONINE TRYPTOPHAN L-ALANINE L-ARGININE L-PROLINE SERINE GLYCINE L-TYROSINE DEXTROSE L-LEUCINE L-PHENYLALANINE LYSINE METHIONINE L-ISOLEUCINE L-VALINE
Strength(s) 240MG 210MG 90MG 1.04G 575MG 340MG 250MG 515MG 20MG 10G 365MG 280MG 290MG 200MG 300MG 290MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 2000mL (JJ7766P)
ATC code B05BA
ATC description I.V. SOLUTIONS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2021-05-14
Actual discontinuation date
Remaining supply date 2021-05-14
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Please refer to customer communication dated June 22, 2020 for a complete list of products being discontinued and CLINIMIX products remaining in the market. Please contact your Baxter Nutrition Sales Specialist if you have any questions or require additional information. For ordering support of any of our products, please contact Baxter Customer Service at 1-888-719-9955.
Health Canada comments
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2020-11-18 French Compare
v7 2020-11-18 English Compare
v6 2020-11-17 French Compare
v5 2020-11-17 English Compare
v4 2020-11-17 French Compare
v3 2020-11-17 English Compare
v2 2020-06-22 French Compare
v1 2020-06-22 English Compare